No Detail Found!

In-silico modeling and in-vitro studies of 2,1-benzothiazine-2,2-dioxide based hydrazone derivatives as α-glucosidase inhibitors

Author(s)
Shakeel Ahmad Department of Chemistry, Government College University,Faisalabad,Pakistan
Saman Taj Department of Bioinformatics and Biotechnology, Government College University,Faisalabad,Pakistan
Sana Aslam Department of Chemistry, Government College Women University,Faisalabad,Pakistan
Samreen Gul Khan Department of Chemistry, Government College University,Faisalabad,Pakistan
Tahir Farooq Department of Applied Chemistry, Government College University,Faisalabad,Pakistan
Usman Ali Ashfaq Department of Bioinformatics and Biotechnology, Government College University,Faisalabad,Pakistan
Matloob Ahmad Department of Chemistry, Government College University,Faisalabad,Pakistan
Abstract
Diabetes mellitus (DM) is a metabolic disorder characterized by frequent urination, hunger and high blood sugar level. a-glucosidase inhibitors are considered as a frontline treatment for the DM. This research article deals with the identification of benzothiazine derivatives as a-glucosidase inhibitors through in-silico techniques and then the confirmation through in-vitro analysis. Molecular docking studies were carried out to find out the binding interactions of targeted molecules with receptor molecule i.e., a-glucosidase enzyme. The synthetic compounds 1 (a-n), 2 (a-d) and 3 (ab) were evaluated for in-vitro alpha glucosidase inhibitory activities that resulted in the discovery of various potent molecules. Majority of the compounds (1c, 1f, 1g, 1k-n, 2a-d and 3a-b) exhibited good inhibitory activity against aglucosidase. Compounds 1c, 1g, 1k and 1m appeared as the potent active compounds with the IC50 values 17.44, 27.64, 24.43, 42.59 and 16.90 µM respectively. Compounds 1c & 2c were found almost 3-folds more active than the standard acarbose. The study may lead to discover potent drug candidates with less complication for the treatment of the type II diabetes mellitus.
Publication Details
Page(s) 1951-1955
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: SUP5, Year: 2021

Request the full text from PASTIC

Keywords
1-Benzothiazine 2, cardiovascular (CV), 2-dioxides, a-glucosidase enzyme, diabetes mellitus (DM), 2, Hydrazones, Docking studies
References
Ahmad S,Zaib S,Jalil S,Shafiq M,Ahmad M,Sultan S,Iqbal M,Aslam S,Iqbal J .2018 .Synthesis, characterization, monoamine oxidase inhibition, molecular docking and dynamic simulations of novel 2, 1-benzothiazine-2, 2-dioxide derivatives. Bioorganic Chem, 80 : 498-510.
Abid SMA,Aslam S,Zaib S,Bakht SM,Ahmad M,Athar MM,Gardiner JM,Iqba J JM .2017 .Pyrazolobenzothiazine-based carbothioamides as new structural leads for the inhibition of monoamine oxidases: Design, synthesis, in vitro bioevaluation and molecular docking studies. Med, 8(2) : 452-464.
Ahmad M,Aslam S,Bukhari MH,Montero C,Detorio M,Parvez M,Schinazi RF M .2014 .Synthesis of novel pyrazolobenzothiazine 5, 5-dioxide derivatives as potent anti-HIV-1 agents. , 23(3) : 1309-1319.
Badshah SL,Naeem A .2016 .Bioactive thiazine and benzothiazine derivatives: Green synthesis methods and their medicinal importance. Molecules, 21(8) : 1054.
Cardullo N,Muccilli V,Pulvirenti L,Cornu A,Pouysegu L,Deffieux D,Tringali C .2020 .C-glucosidic ellagitannins and galloylated glucoses as potential functional food ingredients with anti-diabetic properties: A study of α-glucosidase and α-amylase inhibition. Food chemistry, 313 : 126099.
Chen JG,Wu SF,Zhang QF,Yin ZP,Zhang L ZP .2020 .α-Glucosidase inhibitory effect of anthocyanins from Cinnamomum camphora fruit: Inhibition kinetics and mechanistic insights through in vitro and in silico studies. Int. J. Biol. Macromol, 143(15) : 696-703.
Dinparast L,Valizadeh H,Bahadori MB,Soltani S,Asghari B,Rashidi MR .2016 .. J. Mol. Struct, 1114 : 84-94.
Holman RR,Coleman RL,Chan JC,Chiasson JL,Feng H,Ge J,Wang C .2017 .Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol., 5(11) : 877-886.
Joshi SR,Standl E,Tong N,Shah P,Kalra S,Rathod R .2015 .Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidencebased review. Expert Opin, 16(13) : 1959-1981.
Khalid Z,Aslam S,Ahmad M,Munawar MA,Montero C,Detorio M,Schinazi RF M .2015 .Anti-HIV activity of new pyrazolobenzothiazine 5,5-dioxide-based acetohydrazides. Med. Chem. Res., 24(10) : 3671-3680.
Mancini A,Chelini A,Di Capua A,Castelli L,Brogi S,Paolino M,Giuliani G,Cappelli A,Frosini M,Ricci L,Leonelli E .2017 .Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents. Eur. J. Med, 126 : 614-30.
Saddique FA,Ahmad M,Ashfaq UA,Ahmad MN,Anjum MN,Mohsin NUA,Aslam S NUA .2019 .Alphaglucosidase inhibition and molecular docking studies of 1, 2-benzothiazine 1, 1-dioxide based carbohydrazides. Pak. J. Pharm. Sci., 32(6 Supp)) : 2829-2834.
Satoh T,Igarashi M,Yamada S,Takahashi N,Watanabe K .2015 .Inhibitory effect of black tea and its combination with acarbose on small intestinal α- glucosidase activity. J. Ethnopharmacol., 161 : 147-155.
Sebbar NK,Mekhzoum MEM,Essassi EM,Zerzouf A,Talbaoui A,Bakri Y,El Ammari L Y .2016 .Novel 1, 4-benzothiazine derivatives: synthesis, crystal structure and anti-bacterial properties. Res. Chem, 42(9) : 6845-6862.
Shabbir A,Shahzad M,Ali A,Zia-ur-Rehman M .2016 .Discovery of new benzothiazine derivative as modulator of pro-and anti-inflammatory cytokines in rheumatoid arthritis. Inflammation, 39(6) : 1918-1929.
Taj S,Ashfaq UA,Aslam S,Ahmad M,Bhatti SH .2019 .Alpha-glucosidase activity of novel pyrazolobenzothiazine 5, 5-dioxide derivatives for the treatment of diabetes mellitus. In vitro combined with molecular docking approach. , 74(11) : 1523-30.
Ukrainets IV,Petrushova LA,Sidorenko LV,Davidenko AA,Duchenko MA,-dioxo- MA .2016 .- carboxylic acid toluidides and xylidides. -2λ6, 84(3) : 497-506.
0

Citations

0

Downloads

11

Views